Cargando…

The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation

BACKGROUND: The neural transcription factor SOX11 has been described as a prognostic marker in epithelial ovarian cancers (EOC), however its role in individual histological subtypes and tumour grade requires further clarification. Furthermore, methylation-dependent silencing of SOX11 has been report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sernbo, Sandra, Gustavsson, Elin, Brennan, Donal J, Gallagher, William M, Rexhepaj, Elton, Rydnert, Frida, Jirström, Karin, Borrebaeck, Carl AK, Ek, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187763/ https://www.ncbi.nlm.nih.gov/pubmed/21943380 http://dx.doi.org/10.1186/1471-2407-11-405

Ejemplares similares

SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies
por: Gustavsson, Elin, et al.
Publicado: (2010)

Nuclear T-STAR Protein Expression Correlates with HER2 Status, Hormone Receptor Negativity and Prolonged Recurrence Free Survival in Primary Breast Cancer and Decreased Cancer Cell Growth In Vitro
por: Sernbo, Sandra, et al.
Publicado: (2013)

Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
por: Brennan, Donal J, et al.
Publicado: (2010)

Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer
por: Rexhepaj, Elton, et al.
Publicado: (2010)

Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer
por: Rexhepaj, Elton, et al.
Publicado: (2008)

Expanded clinical and experimental use of SOX11 - using a monoclonal antibody
por: Nordström, Lena, et al.
Publicado: (2012)

DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells
por: Nordström, Lena, et al.
Publicado: (2015)

Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
por: Borgquist, Signe, et al.
Publicado: (2008)

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
por: O´Leary, Patrick C, et al.
Publicado: (2013)

Identification of a myometrial molecular profile for dystocic labor
por: Brennan, Donal J, et al.
Publicado: (2011)

Protein Microarray Technologies for Detection and Identification of Bacterial and Protein Analytes
por: Wingren, Christer, et al.
Publicado: (2008)

Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro
por: Lanigan, Fiona, et al.
Publicado: (2010)

Skin Sensitization Testing—What’s Next?
por: Grundström, Gunilla, et al.
Publicado: (2019)

Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
por: Sjöberg, Elin, et al.
Publicado: (2016)

The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor
por: Coe, Elizabeth A., et al.
Publicado: (2019)

Allergen-Specific Immunotherapy Alters the Frequency, as well as the FcR and CLR Expression Profiles of Human Dendritic Cell Subsets
por: Lundberg, Kristina, et al.
Publicado: (2016)

Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes
por: Thorell, Kaisa, et al.
Publicado: (2009)

SOX17 is a tumor suppressor in endometrial cancer
por: Zhang, Yongli, et al.
Publicado: (2016)

Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators
por: Borgquist, Signe, et al.
Publicado: (2007)

Grading Breast Cancer Tissues Using Molecular Portraits
por: Olsson, Niclas, et al.
Publicado: (2013)

Tumour suppressor 15-hydroxyprostaglandin dehydrogenase induces differentiation in colon cancer via GLI1 inhibition
por: Satapathy, Shakti Ranjan, et al.
Publicado: (2020)

Tumor tissue protein signatures reflect histological grade of breast cancer
por: Skoog, Petter, et al.
Publicado: (2017)

A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests
por: Johansson, Henrik, et al.
Publicado: (2011)

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study
por: Nordström, Lena, et al.
Publicado: (2014)

Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray
por: Möllerström, Elin, et al.
Publicado: (2010)

Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival
por: Nodin, Björn, et al.
Publicado: (2010)

A Texture Based Pattern Recognition Approach to Distinguish Melanoma from Non-Melanoma Cells in Histopathological Tissue Microarray Sections
por: Rexhepaj, Elton, et al.
Publicado: (2013)

Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
por: Brennan, Donal J, et al.
Publicado: (2011)

Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

The metastasis suppressor SOX11 is an independent prognostic factor for improved survival in gastric cancer
por: QU, YING, et al.
Publicado: (2014)

miR-126 Functions as a Tumor Suppressor in Osteosarcoma by Targeting Sox2
por: Yang, Chenglin, et al.
Publicado: (2013)

SOX1 Functions as a Tumor Suppressor by Repressing HES1 in Lung Cancer
por: Chang, Shan-Yueh, et al.
Publicado: (2023)

ING Proteins: Tumour Suppressors or Oncoproteins
por: Jacquet, Karine, et al.
Publicado: (2021)

SOX14 hypermethylation as a tumour biomarker in cervical cancer
por: Zhao, Jing, et al.
Publicado: (2021)

Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
por: Lundgren, Sebastian, et al.
Publicado: (2016)

High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
por: Ahlin, Cecilia, et al.
Publicado: (2017)

Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9
por: Sang, Qiuling, et al.
Publicado: (2018)

SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling
por: Prévostel, Corinne, et al.
Publicado: (2016)

Tumor-suppressor gene SOX1 is a methylation-specific expression gene in cervical adenocarcinoma
por: Yuan, Min, et al.
Publicado: (2019)

ATP and MO25α Regulate the Conformational State of the STRADα Pseudokinase and Activation of the LKB1 Tumour Suppressor
por: Zeqiraj, Elton, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jfbhoauss8rd2ll0eob3a4tgsh